Company Profile
Harmony Biosciences Stock Price, News & Analysis
- Ticker:
- HRMY
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Harmony Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
34.16 USD (+2.18%)
Close
Last updated: June 23, 2026 at 00:00
1.98B USD
Market cap
Why the stock is moving
HRMY is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Harmony Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Harmony Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Harmony Biosciences follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Harmony Biosciences sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Harmony Biosciences Announces Poster Presentations at 2026 SLEEP Annual Meeting
Source: Harmony Biosciences
- 02
- 03
- 04
Harmony Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Source: Harmony Biosciences
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Harmony Biosciences (HRMY)?
Harmony Biosciences (HRMY) most recently closed at 34.16 USD, a +2.18% move versus the previous session.
What is the market cap of Harmony Biosciences (HRMY)?
Harmony Biosciences currently has a market capitalization of 1.98B USD on BioPharmSignal.
What does Harmony Biosciences do?
Harmony Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is HRMY stock listed?
Harmony Biosciences (HRMY) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Harmony Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Harmony?
Harmony Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Harmony Biosciences targeting with Harmony?
Harmony Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Biosciences?
Harmony Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.